AstraZeneca that manufactured Covid-19 vaccine 'Covishield',  has announced its global withdrawal, days after admitting that the vaccine has rare side effects. It has cited 'commercial reasons' for th

AstraZeneca withdraws Covid-19 vaccine

If you've had Covishield, the widely used Covid vaccine, here's a heads-up: it's linked to blood clots and low platelet count, although rarely. Just how rare?

Covishield can cause blood clots, low platelet count. Here's all you should know

Prime Minister Narendra Modi and Bill Gates engaged in an interesting conversation on March 29 covering a range of critical topics.

PM Modi interaction with Bill Gates

Health experts are concerned about the coronavirus variant JN.1, first identified in Luxembourg. JN.1 is a sub-variant of Pirola (BA.2.86), which is derived from the Omicron sub-variant. >

New Covid-19 variant JN.1 detected: All you need to know

China has reported an outbreak of influenza-like illness. According to news reports, Chinese hospitals are "overwhelmed with sick children" who have symptoms of respiratory illness. >

Mysterious pneumonia outbreak in China: Here's why the world is worried

A researcher at Wuhan Institute of Virology in China has made astonishing claims about the coronavirus, saying the virus was engineered by China as a "bioweapon". Watch the video to know more. >

China Deliberately Engineered Coronavirus As "Bioweapon": Wuhan Researcher

The government has approved Bharat Biotech's intranasal Covid-19 vaccine, iNCOVACC (BBV154), as a booster dose for those above 18 years of age. How does this needle-free vaccine work and how different is it from the existing ones? To get the answers, Business Standard spoke to Dr Gagandeep Kang, virologist and professor at the Christian Medical College, Vellore. Watch the video for more

All you need to know about world's first nasal vaccine for covid

Business Standard's opinion pages this week focused on moonlighting, Covid threat, free grain scheme, and much more

BS Views of the week: Moonlighting, Covid, PMGKAY, and more

What does India’s rising unemployment rate mean for the country’s economic recovery? What will be the trends and challenges for the banking sector in the new year? And, why does India need higher expenditure on infrastructure to sustain our economic recovery?

BS Views of the week: India's rising unemployment rate

In this interview to Nivedita Mookerji of Business Standard, Dr Amita Gupta, who's also a professor of infectious diseases at the Johns Hopkins School of Medicine, talks about 2022 being more of the same, how the year will have more waves and that Covid will never go away. She explains how the Johns Hopkins Covid dashboard became a household name, while highlighting the weakness in the health infrastructure and data systems in many countries including in India. According to Dr Gupta, Covid19 should be seen as a wakeup call to improve things.

Covid may never go away, more variants in 2022: Johns Hopkins' Amita Gupta

Getting more shots into more arms is also crucial for ensuring that India's economy continues to grow in a sustained manner.  We have done a reality check. Watch the video

How many shots will India need to blunt third Covid wave?

What happened to ambulance sales during the pandemic? Business Standard looked at some of the available data, and the takeaways were quite surprising. Watch the video

Covid impact on ambulance sales: Data & surprising takeaways

Over 22 million Indians lost their jobs in the months of April across the country due to the second wave of Covid-19. Watch Mahesh Vyas, Head, Centre for Monitoring Indian Economy, talk about the impact of coronavirus pandemic on the livelihood of citizens in this video

Covid impact on income: Over 22 million lost their jobs in just 2 months

AIIMS director Randeep Guleria said that as the number of recovered patients rises, clinics have to be developed to deal with the treatment of symptoms which persist beyond the disease. He said there was now a better understanding of post-Covid acute syndrome which can continue 8 to 12 weeks and long Covid which can occur if symptoms continue beyond 12 weeks. Watch this video to understand the post-Covid complications and treatment options as explained by the AIIMS chief.

Post-Covid complications: Symptoms and treatment explained by AIIMS Chief

Coronavirus updates: A decision on the next phase of Covid-19 vaccination was taken at a meeting of the Union Cabinet under the chairmanship of Prime Minister Narendra Modi on February 24. Who is eligible in the second round of vaccination and what are the charges, if any? Will there be a choice in the vaccine? The video answers all your queries in a quick time.

How to get Covid vaccine from March 1: Eligibility, charges, procedure

ppe, suit, protective equipment, coronavirus, covid, doctors, nurses, medic, health worker

Ministry of Health and Family Welfare has identified a list of critical medical equipment and has requested the NPPA to ensure availability of the same in the country

Serum Institute of India CEO Adar Poonawalla said that the coronavirus vaccine will be distributed initially in India and then the company will look at Covax countries, which are mainly in Africa. Serum Institute of India (SII) is conducting clinical trials of AstraZeneca-Oxford's COVID-19 vaccine candidate in India. Watch the full interview.

Who will get Covid vaccine first? Serum CEO on distribution, pricing & Modi

chart

Unless quick steps are taken to clear surplus milk and milk product stocks in the country, the coming flush season will spell bad news for milk farmers, especially small and marginal ones

Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019

The airline posted a pre tax loss of Rs 2842.6 crore in Q1FY21 against a pre tax profit of Rs 1509.4 crore in the same quarter of the last year

Pranab Mukherjee

The news of the former President testing positive for Covid-19 comes on a day when India reported a spike of 62,064 fresh cases on Monday taking the total tally to 2,215,074

Covid-19